Nuclear medicine for the Future

Pierre and Marie Curie knew immediately when they discovered radioactivity how promising it would be for medical research. Bringing progress to the area of nuclear medicine, Orano Med, Orano’s medical subsidiary, has developed a new generation of targeted therapies against cancer using the unique properties of lead-212. Take a detailed look at a lesser-known use of nuclear energy.

Latest articles            Nuclear energy            Climate          Industry          Nuclear medicine          Recycling & waste         

Since the beginning of the 20th century, with Pierre and Marie Curie leading the way, nuclear materials have been used to treat patients (radium) and improve diagnostics through medical imaging (X-rays). Today, nuclear medicine offers more and more accurate diagnostics using scintigraphy and tomography. 

Orano’s expertise in transforming nuclear materials has progressed in recent years with the development of anticancer treatments and medical research using isotopes. This is the case for lead-212. Orano Med, Orano’s medical subsidiary, has developed a new and very promising process to extract and purify lead-212 for targeted alpha therapy, an innovative form of cancer radiotherapy that reduces the impact on healthy cells.

By clicking “I accept Cookies”, you agree with the cookies use to enhance site navigation, analyze site usage and compile statistics. To get more information, please read our Cookies Policy in the Legal Notice